Cognition Therapeutics In... (CGTX)
NASDAQ: CGTX
· Real-Time Price · USD
1.54
-0.12 (-7.23%)
At close: Aug 15, 2025, 3:59 PM
1.57
1.62%
After-hours: Aug 15, 2025, 07:56 PM EDT
Cognition Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 10.74M | 16.43M | 25.01M | 22.01M | 28.53M | 34.67M | 29.92M | 32.97M | 37.19M | 38.81M | 41.56M | 46.61M | 45.77M | 51.51M | 54.72M | 8.31M | 11.3M | 13.37M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.75M | 1.43M | 1.83M | 1.73M | 1.69M | 1.28M | 1.42M | n/a | 3.21M | 2.44M | 372K |
Receivables | 6.29M | 4.78M | 2.69M | 3.37M | 3.1M | 861K | 1.28M | 1.64M | 2.39M | 1.61M | 3.67M | 2.53M | 3.29M | 2.79M | 2.27M | 1.15M | 2.55M | 2.32M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.29M | n/a | -1.8M | 571K | 766K | 235K |
Other Current Assets | 814K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.97M | n/a | 11K | 10K | 65K | 27K |
Total Current Assets | 19.05M | 22.87M | 29.55M | 26.83M | 33.55M | 37.97M | 34.22M | 36.04M | 41.55M | 42.8M | 47.65M | 50.93M | 50.74M | 56.44M | 58.99M | 10.04M | 14.68M | 15.95M |
Property-Plant & Equipment | 573K | 634K | 679K | 749K | 819K | 883K | 941K | 977K | 984K | 1.03M | 1.05M | 937K | 784K | 839K | 145K | 141K | 165K | 188K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 573K | 634K | 679K | 749K | 819K | 883K | 941K | 2.73M | 2.41M | 2.86M | 2.78M | 2.63M | 2.07M | 2.26M | 145K | 3.35M | 2.61M | 560K |
Total Assets | 19.62M | 23.5M | 30.23M | 27.58M | 34.37M | 38.85M | 35.16M | 38.77M | 43.96M | 45.66M | 50.42M | 53.56M | 52.81M | 58.7M | 59.14M | 13.39M | 17.29M | 16.51M |
Account Payables | 771K | 1.82M | 1.98M | 1.9M | 3.03M | 2.64M | 3.69M | 2.86M | 4.06M | 3.12M | 3.22M | 8.09M | 3.3M | 4M | 4.17M | 2.77M | 3.66M | 3.19M |
Deferred Revenue | 1.98M | 1.07M | 1.07M | 1.12M | 1.45M | 1.58M | 1.7M | 910K | 1.06M | 1.65M | 1.7M | 1.6M | 1.28M | 1.32M | 753K | n/a | n/a | n/a |
Short-Term Debt | 198K | 161K | 279K | 188K | 185K | 366K | 544K | 2K | 217K | 427K | n/a | 114K | 161K | 150K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 9.41M | 600K | 1.53M | 9.32M | 1.09M | 604K | 2.89M | 919K | 839K | 480K | 1.53M | 1.17M | 989K | 1.79M | 2.41M | 1.59M | 1.96M | 429K |
Total Current Liabilities | 12.36M | 10.95M | 11.14M | 12.71M | 10.92M | 9.5M | 10.17M | 8.23M | 7.91M | 7.46M | 7.79M | 12.12M | 6.82M | 7.64M | 7.86M | 4.43M | 6.22M | 4.34M |
Long-Term Debt | 229K | n/a | n/a | n/a | n/a | n/a | 520K | n/a | 608K | n/a | n/a | 603K | 404K | 446K | n/a | n/a | 84.76M | 12.69M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | -520K | 1.05M | -608K | 1.76M | n/a | -603K | -404K | -446K | n/a | 95.68M | 9.99M | 67.34M |
Total Long-Term Liabilities | 229K | 280K | 342K | 392K | 440K | 488K | 520K | 1.62M | 1.66M | 2.42M | 2.38M | 2.12M | 2.1M | 2.31M | 4.17M | 95.68M | 94.75M | 80.03M |
Total Liabilities | 12.59M | 11.23M | 11.48M | 13.1M | 11.36M | 9.99M | 10.69M | 9.85M | 9.57M | 9.88M | 10.18M | 14.24M | 8.91M | 9.96M | 7.86M | 100.11M | 100.97M | 84.37M |
Total Debt | 427K | 635K | 814K | 580K | 809K | 1.03M | 1.24M | 737K | 991K | 1.24M | 1.48M | 717K | 967K | 1.4M | n/a | 84.76M | 84.76M | 12.69M |
Common Stock | 65K | 62K | 60K | 41K | 40K | 40K | 32K | 30K | 30K | 29K | 29K | 24K | 22K | 22K | 22K | 1K | 1K | 2K |
Retained Earnings | -190.37M | -183.64M | -175.16M | -167.32M | -157.38M | -150.34M | -141.19M | -133.05M | -126.3M | -121.57M | -115.4M | -110.22M | -103.59M | -97.84M | -94M | -86.67M | -83.56M | -68M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | -195K | -196K | -196K | -195K | -199K | -201K | -200K | -197K | -198K | -196K | -193K | -192K |
Shareholders Equity | 7.03M | 12.27M | 18.75M | 14.48M | 23.01M | 28.86M | 24.47M | 28.93M | 34.39M | 35.78M | 40.25M | 39.32M | 43.9M | 48.74M | 51.27M | -86.72M | -83.68M | -67.85M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |